Paul T Williams1. 1. Lawrence Berkeley National Laboratory, Berkeley, CA.
Abstract
PURPOSE: This study aimed to assess the relationships of running and walking to mortality in diabetic subjects. METHODS: We studied the mortality surveillance between January 1, 1989 and December 31, 2008, of 2160 participants of the National Walkers' and Runners' Health Studies who reported using diabetic medications at baseline. Hazard ratios (HR) and 95% confidence intervals (95% CI) were obtained from Cox proportional hazard analyses for mortality versus exercise energy expenditure (MET-hours per day, 1 MET·h ∼1-km run or a 1.5-km brisk walk). RESULTS: Three hundred and thirty-one diabetic individuals died during a 9.8-yr average follow-up. Merely meeting the current exercise recommendations was not associated with lower all-cause mortality (P = 0.61), whereas exceeding the recommendations was associated with lower all-cause mortality (HR = 0.64, 95% CI = 0.49-0.82, P = 0.0005). Greater MET-hours per day ran or walked was associated with 40% lower risk for all chronic kidney disease-related deaths (HR = 0.60 per MET·h·d(-1), 95% CI = 0.35-0.91, P = 0.02), 31% lower risk for all sepsis-related deaths (HR = 0.69, 0.47-0.94, P = 0.01), and 31% lower risk for all pneumonia and influenza-related deaths (HR = 0.69, 95% CI = 0.45-0.97, P = 0.03). Running or walking ≥1.8 MET·h·d(-1) was associated with 57% reduction in cardiovascular disease (CVD) as an underlying cause of death and 46% lower risk for all CVD-related deaths versus <1.07 MET·h·d. All results remained significant: 1) adjusted for baseline BMI and 2) excluding all deaths within 3 yr of baseline. CONCLUSIONS: These results suggest that 1) exercise is associated with significantly lower all-cause, CVD, chronic kidney disease, sepsis, and pneumonia, and influenza mortality in diabetic patients and 2) higher exercise standards may be warranted for diabetic patients than currently provided to the general population.
PURPOSE: This study aimed to assess the relationships of running and walking to mortality in diabetic subjects. METHODS: We studied the mortality surveillance between January 1, 1989 and December 31, 2008, of 2160 participants of the National Walkers' and Runners' Health Studies who reported using diabetic medications at baseline. Hazard ratios (HR) and 95% confidence intervals (95% CI) were obtained from Cox proportional hazard analyses for mortality versus exercise energy expenditure (MET-hours per day, 1 MET·h ∼1-km run or a 1.5-km brisk walk). RESULTS: Three hundred and thirty-one diabetic individuals died during a 9.8-yr average follow-up. Merely meeting the current exercise recommendations was not associated with lower all-cause mortality (P = 0.61), whereas exceeding the recommendations was associated with lower all-cause mortality (HR = 0.64, 95% CI = 0.49-0.82, P = 0.0005). Greater MET-hours per day ran or walked was associated with 40% lower risk for all chronic kidney disease-related deaths (HR = 0.60 per MET·h·d(-1), 95% CI = 0.35-0.91, P = 0.02), 31% lower risk for all sepsis-related deaths (HR = 0.69, 0.47-0.94, P = 0.01), and 31% lower risk for all pneumonia and influenza-related deaths (HR = 0.69, 95% CI = 0.45-0.97, P = 0.03). Running or walking ≥1.8 MET·h·d(-1) was associated with 57% reduction in cardiovascular disease (CVD) as an underlying cause of death and 46% lower risk for all CVD-related deaths versus <1.07 MET·h·d. All results remained significant: 1) adjusted for baseline BMI and 2) excluding all deaths within 3 yr of baseline. CONCLUSIONS: These results suggest that 1) exercise is associated with significantly lower all-cause, CVD, chronic kidney disease, sepsis, and pneumonia, and influenza mortality in diabeticpatients and 2) higher exercise standards may be warranted for diabeticpatients than currently provided to the general population.
Authors: Gang Hu; Pekka Jousilahti; Noël C Barengo; Qing Qiao; Timo A Lakka; Jaakko Tuomilehto Journal: Diabetes Care Date: 2005-04 Impact factor: 19.112
Authors: Laura N McEwen; Catherine Kim; Mary Haan; Debashis Ghosh; Paula M Lantz; Carol M Mangione; Monika M Safford; David Marrero; Theodore J Thompson; William H Herman Journal: Diabetes Care Date: 2006-02 Impact factor: 19.112
Authors: F B Hu; M J Stampfer; C Solomon; S Liu; G A Colditz; F E Speizer; W C Willett; J E Manson Journal: Ann Intern Med Date: 2001-01-16 Impact factor: 25.391
Authors: William L Haskell; I-Min Lee; Russell R Pate; Kenneth E Powell; Steven N Blair; Barry A Franklin; Caroline A Macera; Gregory W Heath; Paul D Thompson; Adrian Bauman Journal: Med Sci Sports Exerc Date: 2007-08 Impact factor: 5.411
Authors: Nadiyah Abdullah Al-Mountashiri; Amal Mohammad Al-Zhrani; Shereen Fawzy Hafez Ibrahim; Hyder Othman Mirghani Journal: Electron Physician Date: 2017-09-25
Authors: Ana Paula Della Nina de Oliveira; Emanuella Gomes Maia; Flávia Moraes Silva; Ana Paula Bortoletto Martins; Rafael Moreira Claro Journal: Prev Chronic Dis Date: 2018-12-06 Impact factor: 2.830
Authors: Igor Cigarroa; María José Espinoza-Sanhueza; Nicole Lasserre-Laso; Ximena Diaz-Martinez; Alex Garrido-Mendez; Carlos Matus-Castillo; María Adela Martinez-Sanguinetti; Ana Maria Leiva; Fanny Petermann-Rocha; Solange Parra-Soto; Yeny Concha-Cisternas; Claudia Troncoso-Pantoja; Miquel Martorell; Natalia Ulloa; Heather Waddell; Carlos Celis-Morales Journal: Int J Environ Res Public Health Date: 2020-07-24 Impact factor: 3.390